Infection

Article	Citations
Risk factors for Covid-19 severity and fatality: a structured literature review	322
Long COVID, a comprehensive systematic scoping review	182
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics	151
Epidemiology of SARS-CoV-2	147
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients	145
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore	122
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization	108
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia	105
COVID-19 and mucormycosis superinfection: the perfect storm	103
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis	99
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe	97
Long COVID: current definition	90
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carba	84
Clinical and virological features of first human monkeypox cases in Germany	83
Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg	83
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit	82
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)	80
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19	76
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases	75
Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals	64
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper	62
Pulmonary function in patients surviving to COVID-19 pneumonia	61
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies	61
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence	61
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia	60

Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect	60
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada	57
COVID-19: persistence of symptoms and lung alterations after 3–6 months from hospital discharge	53
Recurrence of COVID-19 after recovery: a case report from Italy	52
Cardiac manifestations of COVID-19 in Shenzhen, China	51
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study	50
First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”	49
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis	49
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity	46
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?	46
Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients	46
Antibiotics in the pipeline: a literature review (2017–2020)	44
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia	44
SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19	43
IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection	42
The current therapeutical strategies in human brucellosis	41
Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis	41
Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values	41
Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis	40
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury	39
Monkeypox in-patients with severe anal pain	39
Intrinsic resistance to terbinafine among human and animal isolates of Trichophyton mentagrophytes related to amino acid substitution in the squalene epoxidase	38
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature	37
Characteristics of viral pneumonia in the COVID-19 era: an update	37
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland	34
Severe monkeypox-virus infection in undiagnosed advanced HIV infection	34
Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?	34
Humoral response to SARS-CoV-2 vaccines in people living with HIV	33
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms	33
Hospital at home for the management of COVID-19: preliminary experience with 63 patients	32
The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections	31
Key summary of German national treatment guidance for hospitalized COVID-19 patients	31
Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study	30
Prognostic value of serum amyloid A in patients with COVID-19	30
Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?	30
Preoperative synovial fluid culture poorly predicts the pathogen causing periprosthetic joint infection	30
Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity	29
Adenovirus diseases: a systematic review and meta-analysis of 228 case reports	29
Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients	29
Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report	29
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry	28
An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA	28
The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis	28
Serum citrullinated histone H3 concentrations differentiate patients with septic verses non-septic shock and correlate with disease severity	28
Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?	26
Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia	26
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study	25
Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission	25
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel	25
Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-1	25

State-of-the-art on monkeypox virus: an emerging zoonotic disease	24
Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study	24
Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020	24
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab	24
A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency	23
Outcome of spinal implant-associated infections treated with or without biofilm-active antibiotics: results from a 10-year cohort study	23
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy	23
One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome	22
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2	22
Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?	22
Early experience with remdesivir in SARS-CoV-2 pneumonia	21
COVID-19: vaccination vs. hospitalization	21
Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China	21
DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function	21
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP)	21
COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls	21
Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID	19
Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case	19
Influence of microbiological diagnosis on the clinical course of spondylodiscitis	19
CRISPR-based strategies in infectious disease diagnosis and therapy	19
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination	19
Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism	19
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?	18
Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex	18
Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four cases	18
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society	18
Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic	18
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy	18
On the death of 100 + Italian doctors from COVID-19	17
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients	17
Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing	17
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning	17
The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience	17
Reactive arthritis occurring after COVID-19 infection: a narrative review	17
Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade	17
Worldwide inverse correlation between Bacille Calmette–Guérin (BCG) immunization and COVID-19 mortality	16
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission	16
Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection	16
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study	16
Personalized machine learning approach to predict candidemia in medical wards	16
Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US	15
Renal involvement in COVID-19: focus on kidney transplant sector	15
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients	15
In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers	15
Epidemiology and in vitro activity of ceftazidime–avibactam, meropenem–vaborbactam, imipenem–relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneu	15
Respiratory muscle dysfunction in long-COVID patients	14
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia	14
Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome	14
Renin–angiotensin system inhibitors and mortality in patients with COVID-19	14
Real-time PCR Ct value in SARS-CoV-2 detection: RdRp or N gene?	14
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy	14
High burden of RSV hospitalizations in Germany 2021–2022	14
Myocarditis in admitted patients with dengue fever	14
Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia	14
Sex differences in COVID-19 mortality in the Netherlands	14
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature	14
Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections	13
The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis	13
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial	13
SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany	12
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature	12
Cardiac iron overload promotes cardiac injury in patients with severe COVID-19	12
The presenting characteristics of erythema migrans vary by age, sex, duration, and body location	12
Coronavirus: a comparative analysis of detection technologies in the wake of emerging variants	12
Effects of a 4-year intervention on hand hygiene compliance and incidence of healthcare associated infections: a longitudinal study	12
A simple risk score for mortality including the PCR Ct value upon admission in patients hospitalized due to COVID-19	12
Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study	12
The proportion, species distribution and dynamic trends of bloodstream infection cases in a tertiary hospital in China, 2010–2019	12
Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland	12
Non-invasive ventilation versus mechanical ventilation in hypoxemic patients with COVID-19	12
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors	12
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine	12
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness	12
Successful management of the first reported case in Austria of COVID-19 with ARDS	11
The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy	11
Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitis	11
Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions	11
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis	11
Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases	11
Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections	11

COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences	11
Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review	11
Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018–2020)	11
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study	11
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis	11
Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis	10
Hospitalization for Chagas disease, dengue, filariasis, leishmaniasis, schistosomiasis, strongyloidiasis, and Taenia solium taeniasis/cysticercosis, Italy, 2011–2016	10
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects	10
Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients	10
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry	10
First case of Candida auris isolated from the bloodstream of a Mexican patient with serious gastrointestinal complications from severe endometriosis	10
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study	10
SARS-CoV-2: big seroprevalence data from Pakistan—is herd immunity at hand?	10
In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations	10
Life expectancy of HIV-infected patients followed at the largest hospital in Guinea-Bissau is one-fourth of life expectancy of the background population	10
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017	10
Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France	10
Characteristics and outcomes of acute hepatitis of unknown etiology in Egypt: first report of adult adenovirus-associated hepatitis	10
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series	10
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects	10
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review	9
Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study	9
Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis	9
Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections	9
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs	9
Plasmodium cynomolgi in humans: current knowledge and future directions of an emerging zoonotic malaria parasite	9
Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis	9
First detected geographical cluster of BoDV-1 encephalitis from same small village in two children: therapeutic considerations and epidemiological implications	9
Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study	9
Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy	9
A 2-year retrospective analysis of the prognostic value of MqSOFA compared to lactate, NEWS and qSOFA in patients with sepsis	9
Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility	9
Tecovirimat for the treatment of severe Mpox in Germany	9
Changes in T-lymphocyte subsets and risk factors in human immunodeficiency virus-negative patients with active tuberculosis	9
Risk for infective endocarditis in bacteremia with Gram positive cocci	9
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital	9
Effectiveness of extended shutdown measures during the ´Bundesnotbremse´ introduced in the third SARS-CoV-2 wave in Germany	9
Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study	8
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational st	8
COVID-19: fighting the foe with Virchow	8
Haematological changes in Schistosoma haematobium infections in school children in Gabon	8
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia	8
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests	8
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study	8
Increased risk of death in COVID-19 hospital admissions during the second wave as compared to the first epidemic wave: a prospective, single-centre cohort study in London, UK	8
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study	8
Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany	8
Perspective on the challenges of COVID-19 facing healthcare workers	8
HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy	8
The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis	8
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19	8
Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?	8
Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study	8
Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of communit	8
Will the COVID-19 pandemic slow down in the Northern hemisphere by the onset of summer? An epidemiological hypothesis	8
Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry	8
Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy	8
Abiotrophia defectiva as a cause of infective endocarditis with embolic complications in children	8